CSPC Innovation Pharmaceutical Co Ltd
300765
Company Profile
Business description
CSPC Innovation Pharmaceutical Co Ltd is engaged in the research and development, production, and sales of functional foods and biopharmaceuticals. Its portfolio includes functional ingredients like caffeine, acarbose, glucose (anhydrous), and various xanthine derivatives, along with enzyme products. In addition, it markets nutritional supplements under the Guoweikang brand, such as Vitamin C tablets and B-vitamin lozenges.
Contact
No. 62, Zhangju Road
Luancheng District
Hebei Province
Shijiazhuang051430
CHNT: +86 31167809843
Sector
Consumer Defensive
Stock type
Defensive
Industry
Packaged Foods
Fiscal Year End
31 December 2025
Employees
2,487
Stocks News & Analysis
stocks
Microsoft earnings: Strong, including Azure, but overall guidance is in line
We think Microsoft stock is moderately undervalued.
stocks
After earnings, is Tesla stock a buy, a sell, or fairly valued?
Q3 earnings reflected sequential improvement driven by record auto deliveries and energy storage deployments.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,205.00 | 1.70 | -0.02% |
| CAC 40 | 8,157.29 | 43.59 | -0.53% |
| DAX 40 | 24,118.89 | 5.32 | -0.02% |
| Dow JONES (US) | 47,522.12 | 109.88 | -0.23% |
| FTSE 100 | 9,760.06 | 3.92 | 0.04% |
| HKSE | 26,050.08 | 232.61 | -0.89% |
| NASDAQ | 23,581.14 | 377.33 | -1.57% |
| Nikkei 225 | 52,211.69 | 886.08 | 1.73% |
| NZX 50 Index | 13,544.51 | 85.22 | 0.63% |
| S&P 500 | 6,822.34 | 68.25 | -0.99% |
| S&P/ASX 200 | 8,909.10 | 4.10 | -0.05% |
| SSE Composite Index | 3,961.62 | 25.28 | -0.63% |